Harrington Group Limited

 ASX:HGR ISIN:AU000000HGR9

May 27, 2012

 

OVERVIEW  | NEWS  | MULTIMEDIA  | RESEARCH

News Reader RSS  Harrington Group Limited
 
 Harrington Group Files 510(k) For Saliva Drug Screening Device Oraline
OCT 24, 2007 12:58 - Article Views: 1,882
Harrington Group (ASX: HGR) advises that having completed the necessary studies the Company's subsidiary Sun Biomedical Laboratories (SBL) has filed for US Food and Drug Administration (FDA) 510(k) clearance for the Company's saliva illicit drug screening device OraLine.
 

Site Search
 
    All Languages
Team Trev Zero Race 2010

Companies in the News

ABN Newswire on iPhone/iPad

Download from Apple

Mobile Video TV

qrcode
Scan with your Mobile Phone to view ABN Newswire Video Channel on Mobile
 
City Index - A Better Way To Trade

1,882 Article Views In All Supported Languages
 

RESEARCH